Wei Dong
Impact in
- Cancer Research top 0.5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Molecular Biology top 2%
- Circular RNAs in diseases
- RNA modifications and cancer
- RNA Research and Splicing
- Epigenetics and DNA Methylation
Papers in
-
- Circular RNAs in diseases 23
- RNA modifications and cancer 21
- Epigenetics and DNA Methylation 8
-
- Cancer-related molecular mechanisms research 24
- MicroRNA in disease regulation 22
- Co-authors
- Tianxin Lin (9 shared papers)Hongchang Shen (21 shared papers)Jiajun Du (20 shared papers)Jian Huang (7 shared papers)Junming Bi (7 shared papers)Guangmin Xia (5 shared papers)Meihua Yang (6 shared papers)Mengcheng Wang (3 shared papers)
- Journals
- Scientific Reports (8 papers)Cancer Letters (7 papers)PLoS ONE (5 papers)Oncology Reports (5 papers)Aging (4 papers)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Wei Dong
237 papers receiving 6.2k citations
Wei Dong's Hit Papers
Peers
Comparison fields: 5 of 160
- Cancer Research 1.9k
- Molecular Biology 3.4k
- Hepatology 268
- Parasitology 215
- Oncology 620
Countries citing papers authored by Wei Dong
This map shows the geographic impact of Wei Dong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Dong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Dong more than expected).
Fields of papers citing papers by Wei Dong
This network shows the impact of papers produced by Wei Dong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Dong. The network helps show where Wei Dong may publish in the future.
Co-authors
The 25 scholars most cited alongside Wei Dong, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 249 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 278 | |
| 2 | N6-Methyladenosine–Mediated Up-Regulation of FZD10 Regulates Liver Cancer Stem Cells’ Properties and Lenvatinib Resistance Through WNT/β-Catenin and Hippo Signaling Pathways Hit paper breakdown → | 2023 | 201 |
| 3 | 2012 | 196 | |
| 4 | 2013 | 194 | |
| 5 | 2019 | 138 | |
| 6 | 2018 | 138 | |
| 7 | 2019 | 136 | |
| 8 | 2019 | 124 | |
| 9 | 2011 | 123 | |
| 10 | 2013 | 121 | |
| 11 | 2020 | 120 | |
| 12 | 2015 | 116 | |
| 13 | 2012 | 110 | |
| 14 | 2018 | 101 | |
| 15 | 2016 | 83 | |
| 16 | 2019 | 79 | |
| 17 | 2018 | 76 | |
| 18 | 2019 | 73 | |
| 19 | 2017 | 67 | |
| 20 | 2016 | 65 |
About Wei Dong
Wei Dong is a scholar working on Molecular Biology, Cancer Research, Plant Science, Pulmonary and Respiratory Medicine and Surgery, having authored 249 papers that have together received 6.2k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (24 papers), Circular RNAs in diseases (23 papers), MicroRNA in disease regulation (22 papers), RNA modifications and cancer (21 papers), Plant Stress Responses and Tolerance (12 papers), Plant Molecular Biology Research (10 papers), Ferroptosis and cancer prognosis (8 papers) and Epigenetics and DNA Methylation (8 papers). The work is most often cited by research in Cancer Research (1.9k citations), Molecular Biology (3.4k citations), Hepatology (268 citations), Parasitology (215 citations) and Oncology (620 citations). Wei Dong has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Tianxin Lin, Hongchang Shen, Jiajun Du, Jian Huang, Junming Bi, Guangmin Xia, Meihua Yang, Mengcheng Wang, Langtao Xiao and Qingqing He. Their work appears in journals such as Scientific Reports, Cancer Letters, PLoS ONE, Oncology Reports and Aging.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.